Protected: VIDEO: Talking JOBS Act with Christine Jacobs, SEC Advisory Committee Chair
There is no excerpt because this is a protected post.
Read more »Editors Note August 30, 2011
Summer is winding down, but activity is heating up in the world of healthcare and emerging life sciences. OneMedSentinel continues […]
Read more »Citigroup to Raise $100 million for GSVC
Global Silicon Valley Capital [NASDAQ: GSVC] announces a $7 million investment in Twitter and other tech stocks.
Read more »Financings and business developments in the global diagnostics business
Biocept, Inc., a privately-held CLIA-certified laboratory testing company, and Clarient, Inc. (a GE Healthcare Company) say that they will be collaborating on the commercialization of a proprietary blood test for circulating tumor cells…
Read more »Rodman and Renshaw presenting Companies
SpectraScience 4:55 Tuesday – North Foyer. NanoViricides 3:15 Tuesday – Starlight South ThermoGenesis 10:00 Tuesday – Metropolitan West EpiCept Corporation […]
Read more »Sept 11-13, 2011 Rodman & Renshaw Global Healthcare Conference
Rodman & Renshaw holds its 13th annual Global Investment Health care Conference this September at the Waldorf=Astoria in New York.
Read more »Wound Management Technologies Inks Distribution Deal Worth Initial $2M
Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions, recently announced a major distribution deal with Marketing Media Enterprises.
Read more »September 15, 2011 Proactive Investors One2One Investor Forum
The directors of ImmunoCellular Therapeutics (OTCBB: IMUC), International Stem Cell (OTCBB: ISCO) and OncoSec Medical Incorporated (OTCBB: ONCS) will be presenting.
Read more »Editor’s Note August 23, 2011
OneMedRadio continues to bring you candid interviews with CEOs of some of the most interesting and innovative micro-cap healthcare and […]
Read more »ThermoGenesis Sees Explosive Growth Opportunities in Stem Cells
Mel Engle, CEO of ThermoGenesis [NASDAQ: KOOL] recently discussed with OneMedRadio, the company’s stem cell products and FDA approval that may have groundbreaking implications for the stem cell market.
Read more »